Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study
Nemati R, Sohrabi-Ashlaghi A, Saberian P, Sadeghi M, Mardani S, Abadi A, Yaghoobpoor A, Heydari A, Khoshroo N, Rahnama Y, Mayeli M, Nasiri H. Growth associated protein 43 (GAP-43) predicts brain amyloidosis in Alzheimer’s dementia continuum: an [18 F] AV-45 study. BMC Neurology 2025, 25: 134. PMID: 40170060, PMCID: PMC11959801, DOI: 10.1186/s12883-025-04140-5.Peer-Reviewed Original ResearchConceptsAssociated with Alzheimer's diseaseMild cognitive impairmentMild cognitive impairment groupStandardized uptake value ratioAlzheimer's Disease Neuroimaging InitiativePET standardized uptake value ratioEarly stages of ADAmyloid-betaGAP-43Tau pathologyGAP-43 levelsAssociated proteinSynaptic dysfunctionStages of ADAV-45Mild cognitive impairment stageBrain amyloidosisAlzheimer's diseaseDementia continuumCognitive impairmentProtein 43Synaptic plasticityDiagnosis of ADProteinGrowth-associated protein
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply